Загрузка...
Heterologous boosting with recombinant VSV-846 in BCG-primed mice confers improved protection against Mycobacterium infection
Tuberculosis (TB) remains a major health problem worldwide, and the development of effective vaccines is urgently needed. Vaccination strategies based on heterologous prime–boost protocols using Mycobacterium bovis bacillus Calmette-Guérin (BCG) as primer and modified vaccinia virus Ankara strain ex...
Сохранить в:
| Опубликовано в: : | Hum Vaccin Immunother |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Taylor & Francis
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5404650/ https://ncbi.nlm.nih.gov/pubmed/27960596 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2016.1261229 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|